Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|15|1571-1596

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.15, 2016-05, pp. : 1571-1596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADAM17 as a Therapeutic Target in Multiple Diseases

By  

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2319-2335

Bentham Science Publishers

Access to resources Recommend Favorite

B cells as a therapeutic target in autoimmune diseases

By Park Yong Wook   Pryshchep Sergey   Seyler Thorsten M   Goronzy Jörg J   Weyand Cornelia M  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 431-445

Informa Healthcare

Access to resources Recommend Favorite

NF-&kgr;B: a therapeutic target in inflammatory diseases

By Curran C.L.   Blackwell T.S.   Christman J.W.  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 2, 2001-04 ,pp. : 197-204

Informa Healthcare

Access to resources Recommend Favorite

NF-&kgr;B as a therapeutic target in neurodegenerative diseases

By Camandola Simonetta   Mattson Mark P  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 123-132

Informa Healthcare

Access to resources Recommend Favorite

Serum S-100B Protein as A Biochemical Marker of Brain Injury: A Review of Current Concepts

By  

Current Medicinal Chemistry, Vol. 13, Iss. 30, 2006-01 ,pp. : 3719-3731

Bentham Science Publishers

Access to resources Recommend Favorite